West Branch Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
West Branch Capital's LLY Position: Q3 2026 in Review
West Branch Capital increased its Eli Lilly (LLY) stake by 0.52% in Q3 2026, buying an estimated $53.1K and bringing the position to 8,748 shares worth $10.1M. The position accounts for 2.29% of the portfolio, ranked #10.
West Branch Capital first reported a position in LLY in Q2 2020 and has held it in 25 quarters since. The position peaked at $10.4M in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- West Branch Capital held 8,748 shares of Eli Lilly worth $10.1M as of Q3 2026.
- West Branch Capital bought 45 Eli Lilly shares in Q3 2026, an estimated $53.1K.
- Eli Lilly made up 2.29% of West Branch Capital's portfolio in Q3 2026, its #10 holding.
- West Branch Capital first reported a position in Eli Lilly in Q2 2020 and has held it in 25 quarters since.
- West Branch Capital's Eli Lilly position peaked at $10.4M in Q2 2026.
- 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on West Branch Capital's 13F filing for Q3 2026, filed 20 Oct 2026.